共 50 条
- [1] Nivolumab (Opdivo) plus Ipilimumab (Yervoy) for Metastatic MelanomaMEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1483): : 168 - 168不详
- [2] EMA approved new drugs: ipilimumab (Yervoy) for the treatment of malignant melanomaEUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2012, 19 (06): : 550 - 551Nolan, Mark
- [3] IPILIMUMAB FOR METASTATIC MELANOMADRUGS OF TODAY, 2012, 48 (06) : 381 - 393Ozao-Choy, J.Carvajal, R. D.Hamid, O.
- [5] Ipilimumab approved for metastatic melanomaAMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (09) : 768 - 768Traynor, Kate
- [6] Ipilimumab for metastatic uveal melanomaLANCET ONCOLOGY, 2013, 14 (10): : E394 - E394Gilbert, Judith A.
- [7] Ipilimumab with fotemustine in metastatic melanomaLANCET ONCOLOGY, 2012, 13 (09): : 851 - 852Garbe, Claus
- [8] Ipilimumab for advanced metastatic melanomaEXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (08) : 981 - 982Starz, Hans
- [9] Nivolumab and Ipilimumab in Melanoma Metastatic to the BrainNEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2177 - 2178Mansouri, AlirezaMoraes, Fabio Y.Zadeh, Gelareh
- [10] Combination of SIRT and Ipilimumab in metastatic MelanomaJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 48 - 49Schedel, F.Koehler, M.Weishaupt, C.